Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Indutrade issues two bond loans of in total SEK 1,000 million

Indutrade AB (publ) has issued two senior unsecured bonds of in total SEK 1,000 million with a tenor of 5 years, respectively.The bond loans amounted to in total SEK 1,000 million, with the first bond loan of SEK 800 million carrying a floating rate and the second bond loan of SEK 200 million carrying a fixed rate. The bond loans were issued at a margin of 1.90% against three months STIBOR and the interpolated mid-swap rate, respectively. The transaction generated strong investor demand. The proceeds from the bond issues will be used for refinancing of existing loans and for general

Metsä Group invests in fossil free future by modernising and expanding Mariestad mill in Sweden

Metsä Group press release 9 February 2023Metsä Group, through its tissue business Metsä Tissue, has made a decision to invest in world leading environmental performance in tissue production by modernising and expanding Metsä Tissue’s Mariestad tissue paper mill in Sweden. The investment will increase the availability of locally and sustainably produced tissue products in the Scandinavian market, in which approximately 40% of tissue usage is currently imported. The value of the investment is EUR 370 million and it is one of the largest in the tissue business in Europe and the largest within

Share rewards from Outokumpu’s share-based incentive programs

Outokumpu OyjStock exchange releaseFebruary 9, 2023 at 11.00 am EETShare rewards from Outokumpu’s share-based incentive programs Outokumpu’s Board of Directors has approved the share rewards from Outokumpu’s share-based incentive programs, Performance Share Plan and Restricted Share Pool. For the Performance Share Plan’s plan period 2020–2022, the targets were met in full. Therefore, 1,298,701 gross shares will be delivered to the participants by the end of April 2022. In the Restricted Share Pool, the participants will receive 145,400 gross shares of the plan period 2020–2022,

Invitation to the presentation and Q&A of the interim report

On the 16th of February at 10:00 CET, Speqta will present the interim report for Q4 2022 for shareholders, media and other stakeholders. Participants will be able to follow the presentation via webcast. CEO Fredrik Lindros and CFO Adam Jonsson will present the report, which will be followed by a Q&A session. Questions can be submitted ahead of the webcast, but there will also be opportunities to ask questions live during the webcast. The interim report will be released on February 16 at 07:00 CET. Time: Thursday February 16, 10:00–11:00 CET.Link to the webcast: https://

Invitation to investor presentation – year-end report 2022

STOCKHOLM, February 9, 2023 – Starbreeze AB will publish its year-end report for the full-year 2022 on Thursday, February 16 at 07.30 CET. On the same day, the company will hold a webcast at 10.00 CET.Tobias Sjögren, CEO, and Mats Juhl, CFO, will present the year-end report for the full-year 2022. In connection to the presentation there will be an opportunity to ask questions, or send in your questions ahead of time here .     WEBCAST Time: Thursday, February 16, 10.00 CET Participation: To join the presentation – click here

Quartr signs its first API deal in Asia, partnering up with Smartkarma

Finance software startup Quartr signs an API deal with the Sequoia-backed investment research network Smartkarma, reaching over 250 institutional asset management firms predominantly across Asia. The partnership grants Smartkarma access to Quartr’s database of earnings calls, accompanying documents, reports, and slide decks, providing its customers with a strong foundation to conduct fundamental research. At the same time, this creates a wider distribution channel for the information that public companies provide.STOCKHOLM & NEW YORK - Quartr (www.quartr.com) has passed an additional

New distributor in Malaysia with focus on GRX

Safe at Sea AB (publ) has signed a distributor agreement with Semenanjung Selatan Sdn Bhd for representation on the Malaysian market.Semenanjung Selatan has for many years delivered equipment to rescue- and disaster organizations but most of all to military- and special operations units. The company has for many years successfully established itself as a supplier of high-quality equipment and know-how to authorities, organizations and companies. Providing innovative and high quality products, Semenanjung Selatan will market the entire Safe at Sea product portfolio and establish the

Phase 2 study of breakthrough vaccine against Toxic Shock Syndrome successfully completed

· Phase 2 studies showed the TSS1-T vaccine to be safe and effective, offering potential preventative therapy for vulnerable groups and medical workers · Outcome is also a major step in the battle against MRSA infections · Phase 3 trial preparation underway · Staphylococcal-induced Toxic Shock Syndrome (TSS) is a serious and life-threatening condition affecting at risk patients, including those with compromised immunity and premenopausal women · Methicillin-resistant Staphylococcus aureus (MRSA) is a constant threat to patients and a major financial burden for healthcare

Polygiene Group invites you to a presentation of the fourth quarter 2022

Polygiene Group will publish its quarterly report for the fourth quarter (October-December) on February 16, 2023, at 8.00 CET. In connection to the announcement, Polygiene Group invites you to a video conference on the same day at 10.00 CET.· Presentation of the quarterly report, CEO Ulrika Björk · Review of the financial results, CFO Niklas Blomstedt The conference is expected to last 45 minutes and will be held in English. Registration is made via the link below no later than February 15, 2023. Instructions regarding access to the conference will be sent out via e-mail when you

Riksbank raises policy rate by 0.5 percentage points and, starting in April, will begin selling government bonds

Inflation is far too high and has continued to rise. For inflation to fall and stabilise around the target within a reasonable time, the Executive Board has decided to raise the Riksbank's policy rate by 0.5 percentage points to 3.0 per cent. The policy rate will probably be raised further during the spring. Further, the Executive Board decided that the Riksbank will, with effect from April, sell government bonds to reduce asset holdings at a faster pace.High global inflation and rising policy rates Central banks around the world have rapidly raised their policy rates to bring down

SpareBank1 SR-Bank: Buy-back of Tier 2: SRBANK22 and SRBANK27 PRO

SpareBank1 SR-Bank has bought back NOK 527 million in its Tier 2 bond issue with ticker SRBANK22 (ISIN: NO0010792476) at a cash price of 100.193. There remains NOK 98 million in bonds outstanding in the market after the buy-back. SpareBank1 SR-Bank has bought back NOK 227 million in its Tier 2 bond issue with ticker SRBANK27 PRO (ISIN: NO0010832421) at a cash price of 100.338. There remains NOK 73 million in bonds outstanding in the market after the buy-back. Settlement date 15 February 2023.

The Swedish Companies Registration Office has registered shares issued by OmniCar Holding AB on 29 December 2022

The Swedish Companies Registration Office has registered 17,483,333 shares issued by OmniCar Holding AB (“OmniCar”) on 29 December 2022. As a result, OmniCar’s number of shares increased from 77,867,328 to 95,350,661 and the share capital increased with SEK 1,748,333.3 from SEK 7,786,732.8 to SEK 9,535,066.10. SEK 10,489,999.8 has been paid for the issued and registered shares.In total, the Board of Directors of OmniCar resolved to issue 28,175,000 shares (with an aggregate subscription price of SEK 16,905,000) on 29 December 2022, of which 17,483,333 shares (SEK 10,489,999.8) now have been

Correction: Ambea year end report 2022

The correction refers to missing the word adjusted in the bullet points four in the summary of the fourth quarter (October – December) and full year (January – December) 2022. The correction only applies to the English version. Corrected press release and year-end report follows in its entirety.CEO comment: Strong organic growth continued in the fourth quarter, and our Swedish divisions, Nytida and Vardaga, showed stable underlying earnings, while the strategic shift in Klara generated results. Klara is now making a greater contribution to consolidated earnings, which was evident

UNION therapeutics announces full-year results for 2022 and provides business update

Hellerup, Denmark, February 9, 2023, – UNION therapeutics A/S (“UNION”), a privately held, multi-asset, clinical stage, pharmaceutical development company focused on immunology and infectious disease, announces full-year results for the period January 1 to December 31, 2022. 2022 has been a year of great progress for UNION with several important achievements paving the way for a very exciting 2023, including positive topline results from the Phase 2b study with oral orismilast in psoriasis, advancement of our mid- to late-stage clinical programs with orismilast and niclosamide,

CampX by Volvo Group opens new Incubator track for startups to accelerate sustainable mobility innovations

More than 50 startups have developed their ideas at CampX, the global collaboration hub for innovations by Volvo Group. The concept gives promising startups a physical place to explore and accelerate new ideas together with Volvo Group using an entrepreneurial mindset. Now, Volvo Group is taking the next step by adding a new track called Incubator where early-stage startups are invited to further develop innovations.CampX  by Volvo Group is a global collaboration hub for

Year-End Report, 1 January–31 December 2022

Successful sales strengthen results Photo: Stena Bulk Total incomeQ4: SEK 263.0 (151.2) millionFull year: SEK 686.1 (704.8) millionEBITDAQ4: SEK 203.7 (36.6) millionFull year: SEK 374.1 (–82.6) millionResult before taxQ4: SEK 142.8 (–308.2) millionFull year: SEK 126.1 (–658.2) million Result per share after taxQ4: SEK 2.95 (–6.45)Full year: SEK 2.58 (–13.84) Events in the third quarter · Strong result due to vessel sales. Result for Q4 2021 negatively affected by impairment of SEK 267.7 million. · Delivery of the sold vessels Stena Primorsk and

Outokumpu – Notice to the Annual General Meeting 2023

Outokumpu OyjStock exchange releaseFebruary 9, 2023 at 10.00 am EETOutokumpu – Notice to the Annual General Meeting 2023 Notice is given to the shareholders of Outokumpu Oyj (“Outokumpu” or “Company”) to the Annual General Meeting to be held on Thursday, March 30, 2023 at 1.00 pm EEST at Dipoli congress center in Otaniemi, at the address Otakaari 24, 02150 Espoo, Finland, entrance through the Gala entrance (Juhlaovi). The reception of persons who have registered for the meeting and the distribution of voting tickets will commence at 11.00 am EEST at the meeting venue.

Anders Jonson leaves Quickbit. Daniel Sonesson appointed acting CEO

This morning Quickbit’s Board of Directors and Anders Jonson have agreed to change the acting CEO for Quickbit. The board has appointed Daniel Sonesson as acting CEO.Anders Jonson leaves Quickbit and his role as acting CEO and Chief Operating Officer. During the notice period, Anders Jonson will be available to the new acting CEO and the board to ensure that the transition is as smooth as possible. The board is grateful that Anders Jonson has managed the business during a busy time and secured important components for the company. Anders Jonson stepped into his CEO role when the previous

UPM Biochemicals and HAERTOL Chemie GmbH announce strategic partnership to develop new sustainable coolants

UPM_Haertol_Image_Frostox [UPM Biochemicals and HAERTOL will jointly launch a new range of carbon-neutral engine and battery coolants that will help automakers reduce their carbon footprint.] UPM Biochemicals and HAERTOL will jointly launch a new range of carbon-neutral engine and battery coolants that will help automakers reduce their carbon footprint. (UPM, Helsinki, 9 February 2023 at 10:00 EET) – UPM Biochemicals  and HAERTOL Chemie GmbH  announced a development partnership today that will accelerate the introduction of

AFRY and Ringhals AB, owned by Vattenfall, in a pilot project for new forms of collaborations

The nuclear power industry is entering a phase in which the specialised competencies need to be secured long term. This affects strategies for the provision of expertise, personnel and cooperation with suppliers. To address these issues, Ringhals AB, has chosen AFRY as their trusted partner to carry out a pilot project at their nuclear power plant to modernise the control equipment for the waste facility, where existing ways of working are reviewed and further developed.With this pilot project, Vattenfall and AFRY are challenging existing ways of working with the aim of adding value by

SmartCraft ASA (SMCRT) - Invitation to presentation of fourth quarter 2022 results

SmartCraft ASA | Non-regulatory press releases9 February 2023 - SmartCraft ASA will publish its fourth quarter 2022 financial report on Wednesday 15 February 2023 at 07:00 CET together with the Q4 2022 presentation material on the company website and www.newsweb.no. Investors, analysts, and journalists are welcome to join to an English language webcast presentation of the report on the same day, Wednesday 15 February 2023, at 08:00 CET. Webcast link: https://channel.royalcast.com/landingpage/hegnarmedia/20230215_1/ Presenters: · Chief Executive Officer Gustav Line ·

Year-end Report 2022

Fourth quarter 2022 · Net sales increased to SEK 3,780m (3,509) corresponding to organic sales growth of 2% (2). · Operating profit, excl. items affecting comparability, decreased to SEK 25m (238),corresponding to an operating margin of 0.7% (6.8). · Operating profit includes items affecting comparability of SEK -156m (0). · Profit after tax amounted to SEK -166m (146), corresponding to earningsper share after dilution of SEK -0.98 (0.87). · Operating cash flow amounted to SEK -81m (-2), including a temporarily high amount ofinvestments in fixed assets due to the

ExpreS2ion announces financial results for the fourth quarter and full-year 2022

Hørsholm, Denmark, February 9, 2023– ExpreS2ion Biotech Holding AB (“ExpreS2ion”) today announces its fourth quarter and full-year financial results for 2022. The report is available as an attachment and on ExpreS2ion's website (www.expres2ionbio.com). Below is a summary of the report.CEO Bent U. Frandsen comments “In 2022, ExpreS[2]ion continued its journey towards becoming a stronger and more pipeline-driven biotechnology company with several high-value assets. Excellent progress was achieved in our leading development projects for COVID-19 and breast cancer, and our ExpreS2™ platform

Q4 Report 2022 – invitation to conference call and audiocast

Stockholm, February 9, 2023 - On Thursday, February 16, at 16.00 CET, IRRAS will host a conference call and an online presentation of its Q4 2022 interim report (which will have been published earlier on February 16 at 08.00 CET). The presentation will be held in English. Dial-in number to the teleconference will be received by registering on the link below. After the registration you will be provided phone numbers and a conference ID to access the conference: https://conference.financialhearings.com/teleconference/?id=5005418 The presentation will be webcast and can be accessed

There are no items matching the current filter
There are no more items matching the current filter
Back to top